Dr. Jonathann Kuo

longer, so they can persist for like 18, 19 days in the bloodstream.

So you can just do a dose like every two weeks.

That makes that a lot more usable.

But then there are the newer variants of gene therapy, either plasmid vector, mRNA vectors, or AAV vectors, adenosine virus vectors.

that, um, can actually, you know, produce false statin kind of a little more systemically at a higher doses.

So those are things that I think are really, really interesting in the future.

So these gene therapy pathways.

Yeah.

Uh, I feel good in general.

You know, I have my own little, have you tested your biological age?

Uh,

Yes.

I mean, biological age tests these days are notoriously very inaccurate.

Really?

Yes.

I'll tell you, clinically, they just don't necessarily make a lot of sense, even to this day.

Wow.

I've evaluated all of the ones out there, correlated them with kind of what we're doing in clinic, correlated them with the blood work that we're getting.

I do think they're getting better.

Some of the epigenetic tests are getting better, but they still are not really there yet.